Arjo
company
Nasdaq Stockholm
ISIN SE0010468116 LEI 549300OWGJPYKC6JF790
Follow Arjo
Weekly email: filings, results
Revenue, last year
SEK 11B
−2.6% vs prior year
Net income
SEK 334M
−32.9% vs prior year
EPS, diluted
SEK 1.23
−32.8% vs prior year
Operating cash flow
SEK 1.4B
−5.3% vs prior year
Source: ESEF annual reports · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | SEK 11B | SEK 334M |
| FY24 | SEK 11.3B | SEK 498M |
| FY23 | SEK 11B | SEK 480M |
| FY22 | SEK 10B | SEK 447M |
| FY21 | SEK 9.1B | SEK 742M |
| FY20 | SEK 9.1B | SEK 526M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 42.6% | 6.1% | 3% |
| FY24 | 43.5% | 7.9% | 4.4% |
| FY23 | 43.1% | 8.1% | 4.4% |
| FY22 | 42.2% | 6.9% | 4.5% |
| FY21 | 46.4% | 11.9% | 8.2% |
| FY20 | 45.5% | 9.5% | 5.8% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | SEK 1B |
| FY24 | SEK 1.1B |
| FY23 | SEK 1.7B |
| FY22 | - |
| FY21 | - |
| FY20 | - |
Show the numbers
| Year | Dividends |
|---|---|
| FY25 | SEK 259M |
| FY24 | SEK 245M |
| FY23 | SEK 232M |
| FY22 | SEK 313M |
| FY21 | SEK 232M |
| FY20 | SEK 177M |
- Arjo
- Healthcare median
Show the numbers
| Year | Arjo | Healthcare median |
|---|---|---|
| FY25 | 3% | −30.6% |
| FY24 | 4.4% | −47% |
| FY23 | 4.4% | −58% |
| FY22 | 4.5% | −80.4% |
| FY21 | 8.2% | −71.9% |
| FY20 | 5.8% | −62.2% |